As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
Amgen is introducing Amjevita (adalimumab-atto), a biosimilar to AbbVie’s Humira. Amjevita was the first biosimilar to Humira approved by the Food and Drug Administration in 2016. "With today's ...
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid ...
Adding methotrexate to adalimumab (Humira) in axial spondyloarthritis was associated with reduced immunogenicity, as shown by a lower rate of developing antidrug antibodies, French researchers ...
Today there are many treatments available to control rheumatoid arthritis (RA), and treatment can be tailored to your particular pattern of symptoms and response. The majority of patients with RA now ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results